Multidisciplinary teams are leveraging advanced technologies to explore the link between cardiovascular disease and dementia with an eye toward improving the diagnosis and treatment of both.
In this first magazine of the 2020s, CVB invites the cardiology community to consider new mindsets for a number of areas, from treating dementias to tackling authorizations, documentation and collections.
HHS and CMS have announced Brad Smith will serve as the new director for the Centers for Medicare & Medicaid Innovation at CMS and senior advisor to HHS Secretary Alex Azar for value-based transformation.
A whopping 80% of medical students report a low sense of personal achievement––an indicator of burn out––according to a new study published in The Journal of American Osteopathic Association. And smartphones could be a factor in contributing to burnout.
Research out of Norway suggests obesity, high blood pressure and diabetes could have a lot to do with CVD’s tendency to present later in life in women than in men.
The MIT School of Engineering has announced a new partnership with Takeda Pharmaceuticals Company Limited to use AI technology to ramp up the development of pharmaceutical drugs.
The Trump administration is pursuing a plan to allow the importation of certain drugs from Canada and other countries in an effort to lower drug prices. But the plan isn’t likely to work, according to a Forbes op-ed.
Machine learning can help physicians exclude the presence of obstructive coronary artery disease (CAD) in patients once they undergo coronary artery calcium scoring (CACS), according to new research published in Academic Radiology. Could this help limit unnecessary imaging examinations?
